AI and novel technologies in lung function measurementStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: TBC
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12)Product type:GuidanceProgramme:Health technology evaluationLast updated: 10 February 2025Published: 28 September 2023
Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessment (HTE11)Product type:GuidanceProgramme:Health technology evaluationPublished: 27 September 2023
Artificial intelligence technologies to help detect fractures on X-rays in urgent care: early value assessment (HTE20)Product type:GuidanceProgramme:Health technology evaluationPublished: 14 January 2025
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment (HTE4)Product type:GuidanceProgramme:Health technology evaluationPublished: 9 March 2023
COLOFIT algorithm to guide colorectal cancer pathway referral in primary care: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital front door technologies to gather information for assessments for NHS Talking Therapies for anxiety and depression: Early Value AssessmentStatus:In development | In consultationProgramme:Health technology evaluationConsultation end date: 7 May 2025Expected publication date: 17 July 2025
Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTE17)Product type:GuidanceProgramme:Health technology evaluationPublished: 25 March 2024
Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTE9)Product type:GuidanceProgramme:Health technology evaluationLast updated: 14 December 2023Published: 16 May 2023
Digitally enabled therapies for adults with depression: early value assessment (HTE8)Product type:GuidanceProgramme:Health technology evaluationLast updated: 14 January 2025Published: 16 May 2023
Digital platforms to support cardiac rehabilitation: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 18 November 2025
Digital platforms to support self-management of asthma : early value assessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital support for people with eating disorders: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 13 November 2025
Digital technologies for delivering multidisciplinary weight-management services: early value assessment (HTE14)Product type:GuidanceProgramme:Health technology evaluationLast updated: 6 March 2024Published: 26 October 2023
Digital technologies for managing mild to moderate hip or knee osteoarthritis: early-value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 2 October 2025
Digital technologies for managing non-specific low back pain: early value assessment (HTE16)Product type:GuidanceProgramme:Health technology evaluationPublished: 5 March 2024
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)Product type:GuidanceProgramme:Health technology evaluationPublished: 30 April 2024
Digital technologies to support self-management of COPD: early value assessment (HTE19)Product type:GuidanceProgramme:Health technology evaluationLast updated: 4 February 2025Published: 19 December 2024
Digital technologies to support smoking cessation in secondary care patients: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: TBC
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 7 May 2025
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment (HTE6)Product type:GuidanceProgramme:Health technology evaluationLast updated: 10 August 2023Published: 30 March 2023
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment (HTE3)Product type:GuidanceProgramme:Health technology evaluationLast updated: 5 September 2023Published: 8 February 2023
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment (HTE10)Product type:GuidanceProgramme:Health technology evaluationPublished: 26 September 2023
ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment (HTE5)Product type:GuidanceProgramme:Health technology evaluationLast updated: 14 March 2024Published: 28 March 2023
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTE15)Product type:GuidanceProgramme:Health technology evaluationPublished: 15 November 2023
Virtual ward platform technologies for acute respiratory infections: early value assessment (HTE13)Product type:GuidanceProgramme:Health technology evaluationPublished: 12 October 2023